Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct;51(5):409-415.
doi: 10.1016/j.aott.2017.08.001. Epub 2017 Sep 7.

Association between aspartic acid repeat polymorphism of the asporin gene and risk of knee osteoarthritis: A systematic review and meta-analysis

Mohammad Reza Sobhan  1 , Masoud Mehdinejad  2 , Mohammad Hossein Jamaladini  1 , Mahta Mazaheri  3 , Masoud Zare-Shehneh  3 , Hossein Neamatzadeh  4
Affiliations

Association between aspartic acid repeat polymorphism of the asporin gene and risk of knee osteoarthritis: A systematic review and meta-analysis

Mohammad Reza Sobhan et al. Acta Orthop Traumatol Turc. 2017 Oct.

Abstract

Objective: Studies have assessed the association between aspartic acid (D)-repeat polymorphism in the gene encoding Asporin (ASPN) and knee osteoarthritis (KOA) risk, but the results were inconclusive and contradictory. Therefore, we performed a meta-analysis to investigate the association between ASPN gene D-repeat polymorphism and KOA risk.

Methods: Eligible studies were identified by searching several electronic databases for relevant reports published before September 2016. The pooled odds ratios (ORs) for the association between ASPN polymorphism and KOA and their corresponding 95% confidence intervals (CIs) were estimated using the random- or fixed-effect model.

Results: A total of eleven case-control studies in ten publications with 4610 KOA cases and 3621 controls were included for the ASPN D-repeat polymorphism. Overall, no significant association was detected for D14 allele carrier (D14 vs. D13: OR = 1.10, 95% CI = 0.90-1.36, p = 0.32). Meta-analysis of D14 vs. other alleles and D13 vs. other alleles showed the same pattern of KOA association as the D14 vs. D13 (OR = 1.30, 95% CI = 1.00-1.70, p = 0.06; OR = 0.93, 95% CI = 0.82-1.06, p = 0.33, respectively). Also, in the stratified analysis by ethnicity, no significant association of this polymorphism with risk of KOA was found in the European and Asians populations (OR = 1.05, 95% CI = 0.91-1.21, p = 0.49; OR = 0.98, 95% CI = 0.78-1.23, p = 0.88, respectively).

Conclusions: The present meta-analysis suggests that the ASPN D-repeat polymorphism is not associated with an increased KOA risk. However, future large studies with gene-gene and gene-environment interactions are needed to validate these findings.

Level of evidence: Level III diagnostic study.

Keywords: Asporin; D13 and D14 alleles; Knee; Osteoarthritis; Polymorphism.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow diagram of the study selection process.
Fig. 2
Fig. 2
Forest plot for overall KOA risk associated with the ASPN polymorphism for each of the 10 published studies. A: D14 vs. D13, B: D14 vs. other alleles, and C: D13 vs. other alleles.
Fig. 3
Fig. 3
Begg's funnel plots of ASPN polymorphism and KOA risk for publication bias test. Each point represents a separate study for the indicated association. Horizontal line, mean effect size. A: D14 vs. D13, B: D14 vs. other alleles.
See this image and copyright information in PMC

References

    1. Loeser R. Age-related changes in the musculoskeletal system and the development of osteoarthritis. Clin Geriatr Med. 2010;26(3):371–386. - PMC - PubMed
    1. World Health Organization . 2004. The Global Burden of Disease: 2004 Update.
    1. Jia L., Wang Y., Chen J., Chen W. Efficacy of focused low-intensity pulsed ultrasound therapy for the management of knee osteoarthritis: a randomized, double blind, placebo-controlled trial. Sci Rep. 2016;6:35453. - PMC - PubMed
    1. Heidari B. Knee osteoarthritis prevalence, risk factors, pathogenesis and features: part I. Caspian J Intern Med. 2011;2(2):205–212. - PMC - PubMed
    2. Zhu L., Yang S., Wang S., Gong H., Li L., Wei X. Effectiveness and safety of manufactured Chinese herbal formula for knee osteoarthritis: insights from a systematic review. Evid Based Complement Alternat Med. 2015;2015:1–19. - PMC - PubMed
    1. Zhang Y., Jordan J.M. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010;26:355–369. - PMC - PubMed

Publication types

MeSH terms